DRUGS PROVIDED TO BREAST CANCER PATIENTS WITHIN THE STATE PROGRAMS OF DRUG SUPPLY
The purpose of our research was to analyze the actual practice of medicine in patients with breast cancer in various regions of the Russian Federation in the framework of state programs of drug provision (procurement of essential drugs (EDPP) and of regional benefits (RBP)).Materials and Methods. We...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IRBIS LLC
2016-12-01
|
| Series: | Фармакоэкономика |
| Subjects: | |
| Online Access: | https://www.pharmacoeconomics.ru/jour/article/view/153 |
| _version_ | 1797878931058065408 |
|---|---|
| author | M. V. Avxentyeva V. I. Bogin E. V. Derkach V. V. Omelyanovskiy M. B. Stenina A. V. Tarakanov M. Yu. Frolov |
| author_facet | M. V. Avxentyeva V. I. Bogin E. V. Derkach V. V. Omelyanovskiy M. B. Stenina A. V. Tarakanov M. Yu. Frolov |
| author_sort | M. V. Avxentyeva |
| collection | DOAJ |
| description | The purpose of our research was to analyze the actual practice of medicine in patients with breast cancer in various regions of the Russian Federation in the framework of state programs of drug provision (procurement of essential drugs (EDPP) and of regional benefits (RBP)).Materials and Methods. We collected data on dispensed medicines from 42 regions of the Russian Federation, which accounted for 57.58% of the total population and 58.20% of the total number of breast cancer patients who had been registered in the oncological institutions of the Russian Federation in 2013. We collected and studied data on the antineoplastic agents (L01) and hormonal antineoplastic drugs (L02) dispensed through programs of drug supply from federal and regional budgets in 2013 in the regions of the Russian Federation for patients with a diagnosis of «malignant neoplasm of the breast» (C50 International Classification of Diseases, 10th revision).Results. The number of drugs prescribed to patients with breast cancer in studied regions ranged from 3 to 39 INNs. Among the most commonly used antineoplastic agents were trastuzumab and capecitabine (both used in 92.86% of the regions), and among hormonal antineoplastic drugs were aromatase inhibitors and tamoxifen (95.24% and 100% of the regions of the Russian Federation). Consumption of drugs varied significantly between theregions.Conclusion. Our study revealed significant differences in the consumption of antineoplastic medications among outpatients with breast cancer in different regions of the Russian Federation whose care was funded by federal and regional budgets. |
| first_indexed | 2024-04-10T02:39:49Z |
| format | Article |
| id | doaj.art-33b079dc3cd2495aa01588644081e852 |
| institution | Directory Open Access Journal |
| issn | 2070-4909 2070-4933 |
| language | Russian |
| last_indexed | 2024-04-10T02:39:49Z |
| publishDate | 2016-12-01 |
| publisher | IRBIS LLC |
| record_format | Article |
| series | Фармакоэкономика |
| spelling | doaj.art-33b079dc3cd2495aa01588644081e8522023-03-13T07:48:15ZrusIRBIS LLCФармакоэкономика2070-49092070-49332016-12-019381810.17749/2070-4909.2016.9.3.008-018134DRUGS PROVIDED TO BREAST CANCER PATIENTS WITHIN THE STATE PROGRAMS OF DRUG SUPPLYM. V. Avxentyeva0V. I. Bogin1E. V. Derkach2V. V. Omelyanovskiy3M. B. Stenina4A. V. Tarakanov5M. Yu. Frolov6Russian Presidential Academy of National Economy and Public Administration, Moscow FSBEI HE I.M. Sechenov First MSMU MOH RussiaStand Up to Cancer, Los Angeles, CA, USARussian Presidential Academy of National Economy and Public Administration, Moscow The National Centre for Technology Assessment in Health Care, MoscowRussian Presidential Academy of National Economy and Public Administration, MoscowFederal State Budgetary Institution «N.N. Blokhin Russian Cancer Research Center», MoscowСromos Pharma, MoscowVolgograd State Medical University of Public Health Ministry of the Russian FederationThe purpose of our research was to analyze the actual practice of medicine in patients with breast cancer in various regions of the Russian Federation in the framework of state programs of drug provision (procurement of essential drugs (EDPP) and of regional benefits (RBP)).Materials and Methods. We collected data on dispensed medicines from 42 regions of the Russian Federation, which accounted for 57.58% of the total population and 58.20% of the total number of breast cancer patients who had been registered in the oncological institutions of the Russian Federation in 2013. We collected and studied data on the antineoplastic agents (L01) and hormonal antineoplastic drugs (L02) dispensed through programs of drug supply from federal and regional budgets in 2013 in the regions of the Russian Federation for patients with a diagnosis of «malignant neoplasm of the breast» (C50 International Classification of Diseases, 10th revision).Results. The number of drugs prescribed to patients with breast cancer in studied regions ranged from 3 to 39 INNs. Among the most commonly used antineoplastic agents were trastuzumab and capecitabine (both used in 92.86% of the regions), and among hormonal antineoplastic drugs were aromatase inhibitors and tamoxifen (95.24% and 100% of the regions of the Russian Federation). Consumption of drugs varied significantly between theregions.Conclusion. Our study revealed significant differences in the consumption of antineoplastic medications among outpatients with breast cancer in different regions of the Russian Federation whose care was funded by federal and regional budgets.https://www.pharmacoeconomics.ru/jour/article/view/153breast cancerdrug supplyconsumption of drugslists essential drugs provision program (edpp) and vitally important drugs (vid)standards of specialized medical carerecommendations. |
| spellingShingle | M. V. Avxentyeva V. I. Bogin E. V. Derkach V. V. Omelyanovskiy M. B. Stenina A. V. Tarakanov M. Yu. Frolov DRUGS PROVIDED TO BREAST CANCER PATIENTS WITHIN THE STATE PROGRAMS OF DRUG SUPPLY Фармакоэкономика breast cancer drug supply consumption of drugs lists essential drugs provision program (edpp) and vitally important drugs (vid) standards of specialized medical care recommendations. |
| title | DRUGS PROVIDED TO BREAST CANCER PATIENTS WITHIN THE STATE PROGRAMS OF DRUG SUPPLY |
| title_full | DRUGS PROVIDED TO BREAST CANCER PATIENTS WITHIN THE STATE PROGRAMS OF DRUG SUPPLY |
| title_fullStr | DRUGS PROVIDED TO BREAST CANCER PATIENTS WITHIN THE STATE PROGRAMS OF DRUG SUPPLY |
| title_full_unstemmed | DRUGS PROVIDED TO BREAST CANCER PATIENTS WITHIN THE STATE PROGRAMS OF DRUG SUPPLY |
| title_short | DRUGS PROVIDED TO BREAST CANCER PATIENTS WITHIN THE STATE PROGRAMS OF DRUG SUPPLY |
| title_sort | drugs provided to breast cancer patients within the state programs of drug supply |
| topic | breast cancer drug supply consumption of drugs lists essential drugs provision program (edpp) and vitally important drugs (vid) standards of specialized medical care recommendations. |
| url | https://www.pharmacoeconomics.ru/jour/article/view/153 |
| work_keys_str_mv | AT mvavxentyeva drugsprovidedtobreastcancerpatientswithinthestateprogramsofdrugsupply AT vibogin drugsprovidedtobreastcancerpatientswithinthestateprogramsofdrugsupply AT evderkach drugsprovidedtobreastcancerpatientswithinthestateprogramsofdrugsupply AT vvomelyanovskiy drugsprovidedtobreastcancerpatientswithinthestateprogramsofdrugsupply AT mbstenina drugsprovidedtobreastcancerpatientswithinthestateprogramsofdrugsupply AT avtarakanov drugsprovidedtobreastcancerpatientswithinthestateprogramsofdrugsupply AT myufrolov drugsprovidedtobreastcancerpatientswithinthestateprogramsofdrugsupply |